Pursuant to Regulation 29 of SEBI (listing Obligations and Disclosure Requirements) Regulations, 2015, Caplin Point Laboratories has informed that the meeting of the Board of Directors of the Company is scheduled to be held on Friday, November 02, 2018 to consider, approve and take on record the Un-audited Financial Results for quarter/half year ended September 30, 2018. Accordingly, the Trading Window for dealing in the equity shares of the Company will remain closed for Promoters, Directors, other Connected Persons and Employees of the Company from October 09,2018 to November 04,2018 as per the Company's Code of Conduct to regulate, monitor and report trading by insiders adopted by the Board pursuant to SEBl(Prohibition of Insider Trading) Regulations,2015
The above information is a part of company’s filings submitted to BSE.
| Company Name | CMP |
|---|---|
| Sun Pharma. Inds. | 1884.00 |
| Dr. Reddys Labs. | 1351.50 |
| Cipla | 1463.90 |
| Zydus Lifesciences | 1121.30 |
| Lupin | 2394.50 |
| View more.. | |
Start Research-backed Investing ...Now. Subscribe to Sapphire
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: